A detailed history of Woodline Partners LP transactions in Zai Lab LTD stock. As of the latest transaction made, Woodline Partners LP holds 1,607,962 shares of ZLAB stock, worth $42.5 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
1,607,962
Previous 2,332,684 31.07%
Holding current value
$42.5 Million
Previous $40.4 Million 3.98%
% of portfolio
0.35%
Previous 0.41%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$16.25 - $24.14 $11.8 Million - $17.5 Million
-724,722 Reduced 31.07%
1,607,962 $38.8 Million
Q2 2024

Aug 14, 2024

SELL
$13.72 - $21.55 $3.62 Million - $5.69 Million
-264,152 Reduced 10.17%
2,332,684 $40.4 Million
Q1 2024

May 15, 2024

BUY
$15.95 - $26.8 $9.22 Million - $15.5 Million
578,309 Added 28.65%
2,596,836 $41.6 Million
Q4 2023

Feb 14, 2024

BUY
$22.97 - $30.58 $28 Million - $37.2 Million
1,217,133 Added 151.88%
2,018,527 $55.2 Million
Q3 2023

Nov 14, 2023

BUY
$22.72 - $31.49 $13.1 Million - $18.2 Million
578,362 Added 259.32%
801,394 $19.5 Million
Q2 2023

Aug 14, 2023

SELL
$25.3 - $39.67 $2.88 Million - $4.52 Million
-113,934 Reduced 33.81%
223,032 $6.18 Million
Q1 2023

May 15, 2023

BUY
$30.21 - $48.1 $4.19 Million - $6.68 Million
138,777 Added 70.02%
336,966 $11.2 Million
Q4 2022

Feb 14, 2023

SELL
$22.28 - $38.71 $5.91 Million - $10.3 Million
-265,140 Reduced 57.22%
198,189 $6.08 Million
Q3 2022

Nov 14, 2022

SELL
$34.2 - $51.69 $6.29 Million - $9.51 Million
-183,933 Reduced 28.42%
463,329 $15.8 Million
Q2 2022

Aug 15, 2022

BUY
$23.14 - $49.68 $8.23 Million - $17.7 Million
355,745 Added 122.03%
647,262 $22.4 Million
Q1 2022

May 16, 2022

BUY
$27.77 - $64.4 $8.1 Million - $18.8 Million
291,517 New
291,517 $12.8 Million
Q4 2021

Feb 14, 2022

SELL
$54.9 - $105.21 $3.66 Million - $7.01 Million
-66,660 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$105.0 - $178.37 $1.93 Million - $3.28 Million
-18,399 Reduced 21.63%
66,660 $7.03 Million
Q2 2021

Aug 16, 2021

BUY
$125.11 - $180.0 $770,302 - $1.11 Million
6,157 Added 7.8%
85,059 $15.1 Million
Q1 2021

May 17, 2021

BUY
$126.27 - $191.71 $2.21 Million - $3.36 Million
17,532 Added 28.57%
78,902 $10.5 Million
Q4 2020

Feb 16, 2021

BUY
$81.94 - $135.34 $5.03 Million - $8.31 Million
61,370 New
61,370 $8.31 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.59B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.